Published this week in AJOG, the study found that the test could predict delivery before 37 weeks with 75 percent sensitivity and 74 percent specificity.
In a recent study, a pair of proteins identified women who went on to deliver preterm with specificity and sensitivity of 78 and 80 percent, respectively.
The mass spec-based proteomic test identified women who gave birth at or before 35 weeks gestation with an area under the receiver operating curve of .93.
Cincinnati Children's Hospital Medical Center researchers have uncovered gene expression changes associated with fetal maturity.
This fall the company is rolling out a limited commercial launch of the MRM mass spectrometry-based proteomic test, with a broader launch to come next year.
Members of the small hunter-gatherer group from sub-Saharan Africa carry killer-cell immunoglobulin-like receptor alleles that appear to alter immune function in ways that benefit pregnancy.
In PNAS this week: role for metabolomics in personalized medicine, vaginal microbiome shift linked to preterm birth, and more.
The company has identified 18 proteins that appeared useful in predicting a woman's risk of preterm delivery and aims to winnow that down to a set of eight to 12.
With the additional funding, Sera aims to develop new tests for predicting the risk of preterm birth in women in developing countries, the company said.
Researchers are now seeking collaborators to help develop and commercialize the new assay.
Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.
Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.
Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.
In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.